Frisullo, Giovanni <br/><br/>
CD4+T-bet+, CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment.  [electronic resource] 

 -  Multiple sclerosis (Houndmills, Basingstoke, England)  May 2011 
 - 556-66 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1477-0970 
<br/><br/><label>Standard No.: </label>10.1177/1352458510392263  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Analysis of Variance<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>CD4-Positive T-Lymphocytes--drug effects<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Case-Control Studies<br/>Cells, Cultured<br/>Chi-Square Distribution<br/>Female<br/>Flow Cytometry<br/>Forkhead Transcription Factors--blood<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Interleukin-2 Receptor alpha Subunit--blood<br/>Italy<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--blood<br/>Natalizumab<br/>Phosphorylation<br/>Recurrence<br/>STAT1 Transcription Factor--blood<br/>STAT3 Transcription Factor--blood<br/>T-Box Domain Proteins--blood<br/>T-Lymphocyte Subsets--drug effects<br/>Time Factors<br/>Treatment Outcome<br/>Up-Regulation<br/>Young Adult<br/>T-bet Transcription Factor